Yasuhisa Fujii

58PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 06, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

|Jul 22, 2026
Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

|May 12, 2026
Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study.

|Apr 30, 2026
Editorial Comment on Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma.

|Feb 18, 2026
Bayesian Re-Interpretation of the CheckMate-9ER Final Analysis: Organ-Site and IMDC Risk-Stratified Probabilities of Benefit.

Hiroshi Fukushima, Shugo Yajima, Hiroyuki Sato

|Feb 16, 2026
Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison.

Wei Chen, Soichiro Yoshida, Yasuhisa Fujii

Pageof 10

Frequent Collaborators

35 joint publications

Hajime Tanaka

22 joint publications

Soichiro Yoshida

15 joint publications

Motohiro Fujiwara

14 joint publications

Masaki Kobayashi